Weekly shot to improve blood sugar control in double diabetes
Part of Hormones & metabolism clinical trials.
This trial tests a weekly injection (similar to Ozempic) for people with type 1 diabetes who also have features of type 2 diabetes (often called 'double diabetes'). The goal is to see if this extra treatment can help lower blood sugar and improve overall diabetes management.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are at least 18 years old.
- You have type 1 diabetes, diagnosed before age 35.
- You have been using insulin (multiple injections or an insulin pump) for at least 1 year and know how to adjust your own insulin doses.
- Your body mass index (BMI) is 27 or higher (a measure of weight relative to height).
- You have at least one of these: a family history of type 2 diabetes or obesity, high triglycerides (a type of fat in the blood), or low 'good' cholesterol (HDL).
- Your most recent HbA1c (a blood test measuring average blood sugar over 3 months) was between 7.5% and under 12%, and you use a continuous glucose monitor (like FreeStyle Libre, Dexcom, or Guardian).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether adding a weekly semaglutide injection (a GLP-1 drug) to a closed-loop insulin system can help reduce the need for carb counting in people with type 1 diabetes. It aims to improve blood sugar control and make diabetes management easier.
This study tests a new weekly injection (called NNC0487-0111) against an existing medicine (semaglutide) to see if it helps people with type 2 diabetes lose more weight. Together with standard diabetes care and lifestyle changes, you would receive the study medicine for about a year, and the study team will monitor your health and weight.
This trial tests if adding semaglutide and empagliflozin to your automated insulin delivery system (like a smart pump) can improve blood sugar control for adults with type 1 diabetes. It may help with both glucose levels and weight management.
This study tests an investigational shot (given every two weeks) that may help lower blood sugar in people with type 2 diabetes. Participation involves regular check-ups and blood tests to see how well the treatment works for you.
This study tests a new medication called semaglutide (similar to Ozempic) in people with type 2 diabetes who are already taking metformin. It aims to see if this medication improves blood sugar control and may also help with weight loss.
This study tests a once-weekly injection (HDM1005) to see if it improves blood sugar control in people with type 2 diabetes who are already taking metformin alone or with an SGLT2 inhibitor. It may help lower your A1C levels and manage your weight.
Hear when a new Double Diabetes trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.